Everything about Healthcare News
Novo CEO pressed by Senate to chop price ranges of obesity, diabetic issues medicine CEO Lars Fruergaard Jørgensen told lawmakers the business would look at new talks with insurers about the record charges of Wegovy and copyright if they pledge to keep the medicines on their own formularies.